First Trust Advisors
SGYP

First Trust Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

First Trust Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-17,382
Closed -$39K – 2440
2017
Q4 		$39K Buy
17,382
+4,172
+32% +$10.4K ﹤0.01% 2374
2017
Q3 		$38K Buy
+13,210
New +$45.1K ﹤0.01% 2385

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

First Trust Advisors's SGYP Position: Q1 2018 in Review

First Trust Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2018, closing a stake of 17,382 shares — an estimated $39K sold.

First Trust Advisors first reported a position in SGYP in Q3 2017 and held it in 2 quarters. The position peaked at $39K in Q4 2017. 147 funds tracked by Wall St. Rank hold SGYP as of Q1 2018.

  • First Trust Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2018 after selling out during the quarter.
  • First Trust Advisors sold 17,382 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2018, an estimated $39K.
  • First Trust Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2017 and held it in 2 quarters.
  • First Trust Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $39K in Q4 2017.
  • 147 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2018.

Based on First Trust Advisors's 13F filing for Q1 2018, filed 23 Apr 2018.